PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Clinical trials for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASMS, CASTRATION-RESISTANT trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise in tough prostate cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs (ipilimumab and nivolumab) in 69 men with a specific type of advanced prostate cancer that no longer responds to hormone therapy. The goal was to see if the treatment could shrink tumors or stop the cancer from growing fo…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE2 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Real-World data reveals how two prostate cancer drugs stack up
Knowledge-focused CompletedThis study looked at medical records of over 2,700 men with advanced prostate cancer that no longer responds to hormone therapy. Researchers compared two common treatments, enzalutamide and abiraterone, to see which one helped men live longer and stay on treatment longer. The goa…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC